Trial Profile
A Retrospective, Cohort study to evaluate the long-term effect of intravitreal dexamethasone implant in patients with Non-proliferative Diabetic Retinopathy (NPDR) and Diabetic Macular Edema (DME)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Aug 2018
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- Acronyms DR-Pro-DEX
- 01 Aug 2018 New trial record